Difference between revisions of "MALE5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
 
(6 intermediate revisions by the same user not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 +
 +
__TOC__
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content</big>
 
|+<big>WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content</big>
Line 17: Line 19:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|
 +
==== CHAPTER 2 (TUMOURS OF THE KIDNEY) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Clear_cell_renal_cell_carcinoma|Clear cell renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Multilocular_cystic_renal_neoplasm_of_low_malignant_potential|Multilocular cystic renal neoplasm of low malignant potential]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_papillary_adenoma|Renal papillary adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Papillary_renal_cell_carcinoma|Papillary renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Oncocytoma_of_the_kidney|Oncocytoma of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Chromophobe_renal_cell_carcinoma|Chromophobe renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Other_oncocytic_tumours_of_the_kidney|Other oncocytic tumours of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Collecting_duct_carcinoma|Collecting duct carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Clear_cell_papillary_renal_cell_tumour|Clear cell papillary renal cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mucinous_tubular_and_spindle_cell_carcinoma|Mucinous tubular and spindle cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Tubulocystic_renal_cell_carcinoma|Tubulocystic renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Acquired_cystic_disease-associated_renal_cell_carcinoma|Acquired cystic disease-associated renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Eosinophilic_solid_and_cystic_renal_cell_carcinoma|Eosinophilic solid and cystic renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_cell_carcinoma_NOS|Renal cell carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:TFE3-rearranged_renal_cell_carcinomas|TFE3-rearranged renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:TFEB-altered_renal_cell_carcinomas|TFEB-altered renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:ELOC_(formerly_TCEB1)-mutated_renal_cell_carcinoma|ELOC (formerly TCEB1)-mutated renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Fumarate_hydratase-deficient_renal_cell_carcinoma|Fumarate hydratase-deficient renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Succinate_dehydrogenase-deficient_renal_cell_carcinoma|Succinate dehydrogenase-deficient renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:ALK-rearranged_renal_cell_carcinomas|ALK-rearranged renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:SMARCB1-deficient_renal_medullary_carcinoma|SMARCB1-deficient renal medullary carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_adenoma|Metanephric adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_adenofibroma|Metanephric adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_stromal_tumour|Metanephric stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_kidney|Mixed epithelial and stromal tumour of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Classic_angiomyolipoma_/_PEComa_of_the_kidney|Classic angiomyolipoma / PEComa of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Epithelioid_angiomyolipoma_/_epithelioid_PEComa_of_the_kidney|Epithelioid angiomyolipoma / epithelioid PEComa of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_haemangioblastoma|Renal haemangioblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Juxtaglomerular_cell_tumour|Juxtaglomerular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renomedullary_interstitial_cell_tumour|Renomedullary interstitial cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Ossifying_renal_tumour_of_infancy|Ossifying renal tumour of infancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Congenital_mesoblastic_nephroma|Congenital mesoblastic nephroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Rhabdoid_tumour_of_the_kidney|Rhabdoid tumour of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Clear_cell_sarcoma_of_the_kidney|Clear cell sarcoma of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Nephrogenic_rests_|Nephrogenic rests]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Cystic_partially_differentiated_nephroblastoma|Cystic partially differentiated nephroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 447:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Nephroblastoma|Nephroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 458:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Germ_cell_tumours_of_the_kidney|Germ cell tumours of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 469:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 3 (TUMOURS OF THE URINARY TRACT) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Urothelial_papilloma|Urothelial papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 501:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Inverted_urothelial_papilloma|Inverted urothelial papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 512:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Papillary_urothelial_neoplasm_of_low_malignant_potential|Papillary urothelial neoplasm of low malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 523:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_low-grade|Non-invasive papillary urothelial carcinoma, low-grade]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 534:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_high-grade|Non-invasive papillary urothelial carcinoma, high-grade]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 545:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Urothelial_carcinoma_in_situ|Urothelial carcinoma in situ]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 556:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Invasive_urothelial_carcinoma|Invasive urothelial carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 567:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_papilloma_of_the_urothelial_tract|Squamous papilloma of the urothelial tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 578:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Verrucous_carcinoma_of_the_bladder|Verrucous carcinoma of the bladder]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 589:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Pure_squamous_carcinoma_of_the_urothelial_tract|Pure squamous carcinoma of the urothelial tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Villous_adenoma|Villous adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Adenocarcinoma_NOS|Adenocarcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Urachal_carcinoma|Urachal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Diverticular_carcinoma|Diverticular carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 644:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Littre_gland_adenocarcinoma_of_the_urethra|Littre gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 655:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Skene_gland_adenocarcinoma_of_the_urethra|Skene gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 666:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Cowper_gland_adenocarcinoma_of_the_urethra|Cowper gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 677:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Clear_cell_adenocarcinoma_of_the_urinary_tract|Clear cell adenocarcinoma of the urinary tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 688:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Endometrioid_carcinoma_of_the_urinary_tract|Endometrioid carcinoma of the urinary tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 699:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 4 (TUMOURS OF THE PROSTATE) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_cystadenoma|Prostatic cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 731:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:High-grade_prostatic_intraepithelial_neoplasia|High-grade prostatic intraepithelial neoplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 742:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Intraductal_carcinoma_of_the_prostate|Intraductal carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 753:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_acinar_adenocarcinoma|Prostatic acinar adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 764:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_ductal_adenocarcinoma|Prostatic ductal adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 775:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Treatment-related_neuroendocrine_prostatic_carcinoma|Treatment-related neuroendocrine prostatic carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 786:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenosquamous_carcinoma_of_the_prostate| Adenosquamous carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 797:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Squamous_cell_carcinoma_of_the_prostate| Squamous cell carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 808:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenoid_cystic_(basal_cell)_carcinoma_of_the_prostate| Adenoid cystic (basal cell) carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 819:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_stromal_tumour_of_uncertain_malignant_potential|Prostatic stromal tumour of uncertain malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 830:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_stromal_sarcoma|Prostatic stromal sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 841:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Cystadenoma_of_the_seminal_vesicle|Cystadenoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 873:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_of_the_seminal_vesicle|Adenocarcinoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 884:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_cell_carcinoma_of_the_seminal_vesicle|Squamous cell carcinoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 895:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_seminal_vesicle|Mixed epithelial and stromal tumour of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 906:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 6 (TUMOURS OF THE TESTIS) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Germ_cell_neoplasia_in_situ| Germ cell neoplasia in situ]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 938:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Specific_forms_of_intratubular_germ_cell_neoplasia| Specific forms of intratubular germ cell neoplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 949:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Gonadoblastoma| Gonadoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 960:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Seminoma| Seminoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 971:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Embryonal_carcinoma| Embryonal carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 982:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Yolk_sac_tumour,_postpubertal-type| Yolk sac tumour, postpubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 993:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Choriocarcinoma| Choriocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 1,004:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Placental_site_trophoblastic_tumour| Placental site trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 1,015:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Epithelioid_trophoblastic_tumour| Epithelioid trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 1,026:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Cystic_trophoblastic_tumour| Cystic trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 1,037:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Teratoma,_postpubertal-type|Teratoma, postpubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 1,048:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Teratoma_with_somatic-type_malignancy|Teratoma with somatic-type malignancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 1,059:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mixed_germ_cell_tumours| Mixed germ cell tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 1,070:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Regressed_germ_cell_tumours| Regressed germ cell tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 1,081:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Spermatocytic_tumour|Spermatocytic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 1,092:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Teratoma,_prepubertal-type| Teratoma, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 1,103:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Yolk_sac_tumour,_prepubertal-type|Yolk sac tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 1,114:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Testicular_neuroendocrine_tumour,_prepubertal-type|Testicular neuroendocrine tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 1,125:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_teratoma_and_yolk_sac_tumour,_prepubertal-type|Mixed teratoma and yolk sac tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 1,136:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Leydig_cell_tumour| Leydig cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 1,147:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Sertoli_cell_tumour| Sertoli cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 1,158:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Large_cell_calcifying_Sertoli_cell_tumour|Large cell calcifying Sertoli cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 1,169:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adult_granulosa_cell_tumour| Adult granulosa cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 1,180:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Juvenile_granulosa_cell_tumour| Juvenile granulosa cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 1,191:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Tumours_in_the_fibroma_thecoma_group| Tumours in the fibroma thecoma group]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 1,202:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_sex_cord_stromal_tumour|Mixed sex cord stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 1,213:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Signet_ring_stromal_tumour|Signet ring stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 1,224:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Myoid_gonadal_stromal_tumour|Myoid gonadal stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 1,235:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Sex_cord_stromal_tumour_NOS|Sex cord stromal tumour NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 1,246:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA) ====
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_cystadenoma| Serous cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 1,278:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_tumour_of_borderline_malignancy| Serous tumour of borderline malignancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 1,289:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_cystadenocarcinoma| Serous cystadenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 1,300:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_cystadenoma| Mucinous cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 1,311:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_borderline_tumour| Mucinous borderline tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 1,322:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_cystadenocarcinoma| Mucinous cystadenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 1,333:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Endometrioid_tumours| Endometrioid tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 1,344:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Clear_cell_adenocarcinoma| Clear cell adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 1,355:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Brenner_tumour| Brenner tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 1,366:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenoma_of_the_collecting_ducts_and_rete_testis|Adenoma of the collecting ducts and rete testis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 1,377:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_of_the_collecting_ducts_and_rete_testis|Adenocarcinoma of the collecting ducts and rete testis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,388:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenomatoid_tumour| Adenomatoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,399:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Well-differentiated_papillary_mesothelial_tumour| Well-differentiated papillary mesothelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,410:
 
|
 
|
 
|-
 
|-
 +
|[[MALE5:_Mesothelioma| Mesothelioma]]
 +
|Disease
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Cystadenoma_of_the_epididymis| Cystadenoma of the epididymis]]
 
|Disease
 
|Disease
 
|
 
|
Line 748: Line 1,431:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[MALE5:_Papillary_cystadenoma_of_the_epididymis| Papillary cystadenoma of the epididymis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Adenocarcinoma_of_the_epididymis| Adenocarcinoma of the epididymis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Squamous_cell_carcinoma_of_the_epididymis|Squamous cell carcinoma of the epididymis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Melanotic_neuroectodermal_tumour_of_the_epididymis| Melanotic neuroectodermal tumour of the epididymis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Condyloma_acuminatum|Condyloma acuminatum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Penile_intraepithelial_neoplasia,_HPV-associated|Penile intraepithelial neoplasia, HPV-associated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Differentiated_penile_intraepithelial_neoplasia,_HPV-independent|Differentiated penile intraepithelial neoplasia, HPV-independent]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:HPV-associated_squamous_cell_carcinoma|HPV-associated squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:HPV-independent_squamous_cell_carcinoma|HPV-independent squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Squamous_cell_carcinoma_NOS| Squamous cell carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Penile_adenosquamous_and_mucoepidermoid_carcinomas| Penile adenosquamous and mucoepidermoid carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extramammary_Paget_disease|Extramammary Paget disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Basal_cell_carcinoma_of_the_scrotum|Basal cell carcinoma of the scrotum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 9 (NEUROENDOCRINE NEOPLASMS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Well-differentiated_neuroendocrine_tumour|Well-differentiated neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mixed_neuroendocrine_neoplasms|Mixed neuroendocrine neoplasms]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Paraganglioma|Paraganglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 10 (MESENCHYMAL TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:The_angiofibroma_family_of_tumours|The angiofibroma family of tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Haemangioma|Haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Myointimoma|Myointimoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Myopericytoma|Myopericytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extrarenal_PEComa|Extrarenal PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 11 (HAEMATOLYMPHOID TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Extranodal_marginal_zone_lymphoma_of_MALT|Extranodal marginal zone lymphoma of MALT]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Plasmacytoma|Plasmacytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Juvenile_xanthogranuloma| Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 12 (MELANOCYTIC LESIONS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Mucosal_melanoma|Mucosal melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Metastasis_to_the_urinary_tract|Metastasis to the urinary tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_kidney|Metastasis to the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_testis_and_paratestis|Metastasis to the testis and paratestis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[MALE5:Birt-Hogg-Dube_syndrome|Birt-Hogg-Dube syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_papillary_renal_carcinoma|Hereditary papillary renal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome|Hereditary leiomyomatosis and renal cell carcinoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Succinate_dehydrogenase-deficient_tumour_syndromes|Succinate dehydrogenase-deficient tumour syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 
|-
 
|-
 
|}
 
|}

Latest revision as of 14:09, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (TUMOURS OF THE KIDNEY)
Clear cell renal cell carcinoma Disease
Multilocular cystic renal neoplasm of low malignant potential Disease
Renal papillary adenoma Disease
Papillary renal cell carcinoma Disease
Oncocytoma of the kidney Disease
Chromophobe renal cell carcinoma Disease
Other oncocytic tumours of the kidney Disease
Collecting duct carcinoma Disease
Clear cell papillary renal cell tumour Disease
Mucinous tubular and spindle cell carcinoma Disease
Tubulocystic renal cell carcinoma Disease
Acquired cystic disease-associated renal cell carcinoma Disease
Eosinophilic solid and cystic renal cell carcinoma Disease
Renal cell carcinoma NOS Disease
TFE3-rearranged renal cell carcinomas Disease
TFEB-altered renal cell carcinomas Disease
ELOC (formerly TCEB1)-mutated renal cell carcinoma Disease
Fumarate hydratase-deficient renal cell carcinoma Disease
Succinate dehydrogenase-deficient renal cell carcinoma Disease
ALK-rearranged renal cell carcinomas Disease
SMARCB1-deficient renal medullary carcinoma Disease
Metanephric adenoma Disease
Metanephric adenofibroma Disease
Metanephric stromal tumour Disease
Mixed epithelial and stromal tumour of the kidney Disease
Paediatric cystic nephroma Disease
Classic angiomyolipoma / PEComa of the kidney Disease
Epithelioid angiomyolipoma / epithelioid PEComa of the kidney Disease
Renal haemangioblastoma Disease
Juxtaglomerular cell tumour Disease
Renomedullary interstitial cell tumour Disease
Ossifying renal tumour of infancy Disease
Congenital mesoblastic nephroma Disease
Rhabdoid tumour of the kidney Disease
Clear cell sarcoma of the kidney Disease
Nephrogenic rests Disease
Cystic partially differentiated nephroblastoma Disease
Nephroblastoma Disease
Germ cell tumours of the kidney Disease

CHAPTER 3 (TUMOURS OF THE URINARY TRACT)
Urothelial papilloma Disease
Inverted urothelial papilloma Disease
Papillary urothelial neoplasm of low malignant potential Disease
Non-invasive papillary urothelial carcinoma, low-grade Disease
Non-invasive papillary urothelial carcinoma, high-grade Disease
Urothelial carcinoma in situ Disease
Invasive urothelial carcinoma Disease
Squamous papilloma of the urothelial tract Disease
Verrucous carcinoma of the bladder Disease
Pure squamous carcinoma of the urothelial tract Disease
Villous adenoma Disease
Adenocarcinoma NOS Disease
Urachal carcinoma Disease
Diverticular carcinoma Disease
Littre gland adenocarcinoma of the urethra Disease
Skene gland adenocarcinoma of the urethra Disease
Cowper gland adenocarcinoma of the urethra Disease
Clear cell adenocarcinoma of the urinary tract Disease
Endometrioid carcinoma of the urinary tract Disease

CHAPTER 4 (TUMOURS OF THE PROSTATE)
Prostatic cystadenoma Disease
High-grade prostatic intraepithelial neoplasia Disease
Intraductal carcinoma of the prostate Disease
Prostatic acinar adenocarcinoma Disease
Prostatic ductal adenocarcinoma Disease
Treatment-related neuroendocrine prostatic carcinoma Disease
Adenosquamous carcinoma of the prostate Disease
Squamous cell carcinoma of the prostate Disease
Adenoid cystic (basal cell) carcinoma of the prostate Disease
Prostatic stromal tumour of uncertain malignant potential Disease
Prostatic stromal sarcoma Disease

CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE)
Cystadenoma of the seminal vesicle Disease
Adenocarcinoma of the seminal vesicle Disease
Squamous cell carcinoma of the seminal vesicle Disease
Mixed epithelial and stromal tumour of the seminal vesicle Disease

CHAPTER 6 (TUMOURS OF THE TESTIS)
Germ cell neoplasia in situ Disease
Specific forms of intratubular germ cell neoplasia Disease
Gonadoblastoma Disease
Seminoma Disease
Embryonal carcinoma Disease
Yolk sac tumour, postpubertal-type Disease
Choriocarcinoma Disease
Placental site trophoblastic tumour Disease
Epithelioid trophoblastic tumour Disease
Cystic trophoblastic tumour Disease
Teratoma, postpubertal-type Disease
Teratoma with somatic-type malignancy Disease
Mixed germ cell tumours Disease
Regressed germ cell tumours Disease
Spermatocytic tumour Disease
Teratoma, prepubertal-type Disease
Yolk sac tumour, prepubertal-type Disease
Testicular neuroendocrine tumour, prepubertal-type Disease
Mixed teratoma and yolk sac tumour, prepubertal-type Disease
Leydig cell tumour Disease
Sertoli cell tumour Disease
Large cell calcifying Sertoli cell tumour Disease
Adult granulosa cell tumour Disease
Juvenile granulosa cell tumour Disease
Tumours in the fibroma thecoma group Disease
Mixed sex cord stromal tumour Disease
Signet ring stromal tumour Disease
Myoid gonadal stromal tumour Disease
Sex cord stromal tumour NOS Disease

CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA)
Serous cystadenoma Disease
Serous tumour of borderline malignancy Disease
Serous cystadenocarcinoma Disease
Mucinous cystadenoma Disease
Mucinous borderline tumour Disease
Mucinous cystadenocarcinoma Disease
Endometrioid tumours Disease
Clear cell adenocarcinoma Disease
Brenner tumour Disease
Adenoma of the collecting ducts and rete testis Disease
Adenocarcinoma of the collecting ducts and rete testis Disease
Adenomatoid tumour Disease
Well-differentiated papillary mesothelial tumour Disease
Mesothelioma Disease
Cystadenoma of the epididymis Disease
Papillary cystadenoma of the epididymis Disease
Adenocarcinoma of the epididymis Disease
Squamous cell carcinoma of the epididymis Disease
Melanotic neuroectodermal tumour of the epididymis Disease

CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM)
Condyloma acuminatum Disease
Penile intraepithelial neoplasia, HPV-associated Disease
Differentiated penile intraepithelial neoplasia, HPV-independent Disease
HPV-associated squamous cell carcinoma Disease
HPV-independent squamous cell carcinoma Disease
Squamous cell carcinoma NOS Disease
Penile adenosquamous and mucoepidermoid carcinomas Disease
Extramammary Paget disease Disease
Basal cell carcinoma of the scrotum Disease

CHAPTER 9 (NEUROENDOCRINE NEOPLASMS)
Well-differentiated neuroendocrine tumour Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Mixed neuroendocrine neoplasms Disease
Paraganglioma Disease

CHAPTER 10 (MESENCHYMAL TUMOURS)
The angiofibroma family of tumours Disease
Solitary fibrous tumour Disease
Inflammatory myofibroblastic tumour Disease
Haemangioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Myointimoma Disease
Myopericytoma Disease
Extrarenal PEComa Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Rhabdomyosarcoma Disease
Synovial sarcoma Disease
Extrarenal rhabdoid tumour Disease
Desmoplastic small round cell tumour Disease

CHAPTER 11 (HAEMATOLYMPHOID TUMOURS)
Extranodal marginal zone lymphoma of MALT Disease
Diffuse large B-cell lymphoma Disease
Plasmacytoma Disease
Juvenile xanthogranuloma Disease

CHAPTER 12 (MELANOCYTIC LESIONS)
Mucosal melanoma Disease

CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM)
Metastasis to the urinary tract Disease
Metastasis to the kidney Disease
Metastasis to the testis and paratestis Disease

CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS)
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Birt-Hogg-Dube syndrome Disease
Hereditary papillary renal carcinoma Disease
Hereditary leiomyomatosis and renal cell carcinoma syndrome Disease
Succinate dehydrogenase-deficient tumour syndromes Disease
BAP1 tumour predisposition syndrome Disease
Hereditary phaeochromocytoma-paraganglioma syndromes Disease
Tuberous sclerosis Disease
Genitourinary system and Lynch syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Hereditary tumour syndromes associated with homologous recombination pathway mutations Disease
Carney complex Disease
Peutz-Jeghers syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Retrieved from "https://ccga.io/index.php?title=MALE5:Volunteer_Assignments_and_Opportunities&oldid=15424"